Peptide and Protein Biomarkers for Amyotrophic Lateral Sclerosis (ALS)

肌萎缩侧索硬化症 (ALS) 的肽和蛋白质生物标志物

• 批准号: 8335727
• 负责人: ROBERT P BOWSER
• 金额: $ 26万
• 依托单位: ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-06-01 至 2014-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8335727
• 关键词: Adult; Age; Alzheimer' s Disease; Amyotrophic Lateral Sclerosis; Antibodies; Biological Assay; Biological Markers; Brain Stem; Cerebral cortex; Cerebrospinal Fluid; Clinical; Clinical Trials; Collection; Data; Degenerative Disorder; Diagnostic; Disease; Disease Progression; Employee Strikes; Enzyme-Linked Immunosorbent Assay; Future; Gender; Generations; Goals; Health; Immunoblotting; Individual; Inflammation; Label; Lead; Liquid Chromatography; Mass Spectrum Analysis; Measurement; Measures; Methodology; Methods; Molecular; Monitor; Motor Neurons; Multiple Sclerosis; Onset of illness; Oxidative Stress; Pathogenesis; Pathologic; Patients; Peptides; Plasma; Population; Proteins; Proteome; Proteomics; Research; Role; Sampling; Site; Spinal Cord; Symptoms; Testing; Time; Tissues; Validation; Vascular System; Vesicle; base; cell type; diagnostic accuracy; drug efficacy; insight; multiple reaction monitoring; new therapeutic target; novel; tandem mass spectrometry